m_escobarrey Profile Banner
María Escobar Rey Profile
María Escobar Rey

@m_escobarrey

Followers
52
Following
113
Media
0
Statuses
46

PhD student at @CNIOStopCancer | Computational Oncology

Madrid, Comunidad de Madrid
Joined April 2022
Don't wanna be here? Send us removal request.
@Endocrine_CNIO
Hereditary Endocrine Cancer Group @CNIOStopCancer
2 months
Another year, another European Researchers Night #NIGHTMADRID at @CNIOStopCancer. @Endocrine_CNIO and friends ready to rock this exciting event!!
0
5
15
@BHFHeptathlon
Barbara Hernando
2 months
💫 No te puedes perder el evento que hemos organizado para dar a conocer qué hacemos en el @CNIOStopCancer para combatir el cáncer! Te esperamos el próximo jueves en La Excéntrica! +INFO 👇🏻
@CNIOStopCancer
CNIO Stop Cancer
2 months
📢 Llega ¡Una de ciencia, por favor! Tres charlas increíbles de científic@s del #CNIOStopCancer 🔬 🗓 Jueves 18 septiembre ⏰ 19:00 📍 La Excéntrica (C/ Las Fuentes 10)🍻 RESERVA: https://t.co/zlr9sWx7Xg INFO - https://t.co/2vb3ZgMoL7 @unadecienciaporfavor Organiza: CNIO-PDA
0
1
0
@Endocrine_CNIO
Hereditary Endocrine Cancer Group @CNIOStopCancer
3 months
Attention!! Job opening in our group. Please spread the word!! Advanced Degree for the Hereditary Endocrine Cancer Group - CNIO: https://t.co/xeNF2slvu0
0
10
10
@JorgeMoreno7
Jorge Moreno
4 months
Una persona anónima ha comprado una página entera del periódico @elmundoes para dedicarle esta esquela a un ser querido. ❤️‍🩹
184
5K
31K
@el_pais
EL PAÍS
5 months
Descubierto un marcador que indica qué pacientes no responderán a la quimioterapia. La genética de sus tumores puede desvelar qué fármaco no funcionará, lo que ayudaría a los oncólogos a aplicar otro tipo de quimio que sí podría tener efecto
elpais.com
Investigadores de España y Reino Unido desarrollan un análisis que podría evitar tratamientos que no tendrán efectividad en pacientes con tumores de ovario, mama, próstata y sarcoma
3
264
713
@gjmacintyre
Geoff Macintyre
5 months
🚨Chemo treatment upgrade!🚨 Check out our approach to modernise chemotherapy treatment published today in @NatureGenet. From @CNIOStopCancer @TailorBio @CR_UK https://t.co/IgUxlRYBgm More details 👇
2
23
45
@BHFHeptathlon
Barbara Hernando
5 months
It’s finally out! 🥳 We are super happy to see our biomarkers for predicting resistance to chemotherapy! More info 👇🏻 & in the “behind the paper” post
Tweet card summary image
communities.springernature.com
Some of the most successful cancer drugs - chemotherapies - are still being administered in the same way they were 40 years ago: one-size-fits-all. New diagnostic advances should allow us to be more...
@gjmacintyre
Geoff Macintyre
5 months
🚨Chemo treatment upgrade!🚨 Check out our approach to modernise chemotherapy treatment published today in @NatureGenet. From @CNIOStopCancer @TailorBio @CR_UK https://t.co/IgUxlRYBgm More details 👇
1
3
16
@gjmacintyre
Geoff Macintyre
5 months
If tumour genome evolution is deterministic, can we forecast genomic changes? Yes we can! At least for oncogene amps and tumour suppressor dels. @BHFHeptathlon @Sanroman_Fern present our method for forecasting driver gene copy number change. Preprint: https://t.co/sCasdMrXBp ⬇️1/
Tweet card summary image
biorxiv.org
Oncogene amplification and tumour suppressor deletion can drive tumour initiation, progression and treatment resistance. Detection at diagnosis often signals poor prognosis, but it can also enable...
1
16
37
@BHFHeptathlon
Barbara Hernando
7 months
Day 1 at #AACR2025 from my side! Meanwhile, at the #EMBO workshop on Chromosome Segregation and Aneuploidy, @m_escobarrey will be presenting our project on ongoing CIN in KRAS mutant pancreatic organoids! A must meeting for the #CIN community
1
2
9
@CNIOStopCancer
CNIO Stop Cancer
9 months
“Sé que tienes un montón de dudas”, “confía en ti misma”, “¡no te preocupes si te dicen que haces muchas preguntas!”. Investigadoras del #CNIOStopCancer, recuerdan a las niñas que fueron para llegar a las niñas de hoy. #11F2025 #mujeryciencia #11F https://t.co/mDwJWpKKFY
Tweet card summary image
cnio.es
“Sé que tienes un montón de dudas”, “confía en ti misma”, “¡no te preocupes si te dicen que haces muchas preguntas!”. Seis investigadoras que hoy están en el principal centro público español destin...
0
5
18
@gjmacintyre
Geoff Macintyre
10 months
We are hiring! Opportunity for a project manager to oversee all aspects of a multi-centre clinical research project to implement an AI-based genomic test that predicts resistance to chemotherapy - Madrid, Spain. PM for more details. Deadline 25 January!
0
11
13
@blaschaves_
Blas Chaves-Urbano
1 year
This week I had the opportunity to attend the 19th @ASEICAnews congress held in Zaragoza. What a week of amazing science and networking! So happy to be there with my lab colleagues from @CNIOStopCancer 😍! (Fantastic photo📸 from @ASEICAnews)
1
3
26
@RogerGom1
GomisLab
1 year
Happy to contribute at the meet the expert session @ASEICAnews
0
4
20
@BHFHeptathlon
Barbara Hernando
1 year
I presented today the work we are doing in the @gjmacintyre lab at the @CNIOStopCancer to tackle CIN tumours. The team will be at the @ASEICAnews conference presenting the projects currently running in the lab! Visit posters #78 #97 #123 #258 ✌🏻
@ASEICAnews
ASEICA
1 year
@FundIbercaja @Beiii22 @KassYoussef_K @EspeePozo @msmelanoma @CuendaAna @TheAnaJanic @patriciacj_4 @ismael_perise @PeioAzcoaga @VCepasLopez @SaraManzCiencia @ARNesLab @imendizabal1 @BHFHeptathlon Some more moments from our last scientific session 🔬 Thank you for sharing your work and progress in cancer research 💪 @ARNesLab Joan Russo @imendizabal1 @BHFHeptathlon María Salazar-Roa #ASEICAJoven Retreat 📍 @FundIbercaja
1
6
26
@Endocrine_CNIO
Hereditary Endocrine Cancer Group @CNIOStopCancer
1 year
Exitazo en @CaixaForum Madrid! Muchas gracias a todos los participantes! El año que viene os esperamos a todos en @CNIOStopCancer para seguir aprendiendo de nuestra labor en el estudio contra el cáncer #EuropeanResearchersNight #NIGHTSpain @BecariosFLC
@Endocrine_CNIO
Hereditary Endocrine Cancer Group @CNIOStopCancer
1 year
Ready! Miembros del Programa de Genómica del Cáncer del @CNIOStopCancer y del @PGx_IIBM os esperamos a las 18:30 en @CaixaForum Madrid con el Taller "Misión Diagnóstico: ¿Qué esconde nuestro ADN?" en La noche de la Investigación #EuropeanResearchersNight #MADRIDNIGHT #NIGHTSpain
0
7
13
@gjmacintyre
Geoff Macintyre
1 year
Computational postdoc position available! Come join our lab @CNIOStopCancer and help better understand the role of chromosomal instability in basic biology, tumour evolution, and diagnostics. #ComputationalOncology #CIN #Postdocs
1
28
28
@BHFHeptathlon
Barbara Hernando
1 year
👇 Lo ➕ positivo es trabajar con este pedazo equipo! @m_escobarrey @blaschaves_ @alicecadiz_ @gjmacintyre @Sanroman_Fern #Patricia #David #Joe #CINteam
@CNIOStopCancer
CNIO Stop Cancer
1 year
@BarrisLluis @BHFHeptathlon @brunacalsina @mariaav5 @elgansospain @morenafilms @Cadenaser_espa @NachoSolana @valientelab ⚽Despeja el esférico (y los datos) @bhfheptathlon, desde el Grupo de Oncología Computacional, analizando tumores agresivos de alta inestabilidad. La mejor medalla es "encontrar una forma de ofrecer tratamiento a pacientes con una corta esperanza de vida". https://t.co/XClsJzTGxw
1
3
5
@markowetzlab
Florian Markowetz
1 year
✍️Mark your calendars! 🔥 International lecture series on Chromosomal Instability. 👩‍🔬 July 19th: Bárbara Hernando, CNIO 📢 "Dissecting chromsomal instability for tailored cancer treatment" 🤩 On zoom: https://t.co/iGc21lHkQu
1
13
46
@gjmacintyre
Geoff Macintyre
2 years
Want to use CRISPR to mess with genomes and induce chromosomal instability? 4 year fully funded PhD position available in the Computational Oncology group at @CNIOStopCancer. Come join us in Madrid!
0
14
27
@gjmacintyre
Geoff Macintyre
2 years
Thrilled to share our study predicting response to multiple chemotherapies using a single genomic test! https://t.co/NjF28Dr11d cant wait to move this to clinical trials with @TailorBio to transform chemo into a precision medicine! Collab b/w @TailorBio @CNIOStopCancer @CRUK_CI
Tweet card summary image
biorxiv.org
Cytotoxic chemotherapies have been a crucial part of cancer treatment for over 40 years. While their primary target is cancer cells, they can also harm normal cells, resulting in dose-limiting...
0
16
59